tiprankstipranks
Trending News
More News >
Aurobindo Pharma Ltd (IN:AUROPHARMA)
:AUROPHARMA
India Market

Aurobindo Pharma Ltd (AUROPHARMA) Financial Statements

Compare
0 Followers

Aurobindo Pharma Ltd Financial Overview

Aurobindo Pharma Ltd's market cap is currently ₹636.67B. The company's EPS TTM is ₹15.56; its P/E ratio is 18.33; and it has a dividend yield of 0.41%. Aurobindo Pharma Ltd is scheduled to report earnings on May 26, 2025, and the estimated EPS forecast is ₹17.41. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total Revenue₹ 317.24B₹ 290.02B₹ 246.17B₹ 233.67B₹ 247.75B
Gross Profit₹ 186.97B₹ 160.16B₹ 129.75B₹ 69.38B₹ 80.49B
Operating Income₹ 142.22B₹ 104.50B₹ 25.51B₹ 33.00B₹ 44.76B
EBITDA₹ 66.05B₹ 61.79B₹ 40.09B₹ 45.36B₹ 85.29B
Net Income₹ 34.86B₹ 31.73B₹ 19.27B₹ 26.48B₹ 53.35B
Balance Sheet
Cash & Short-Term Investments₹ 82.36B₹ 63.25B₹ 62.24B₹ 45.58B₹ 56.21B
Total Assets₹ 497.85B₹ 450.72B₹ 398.90B₹ 339.22B₹ 338.54B
Total Debt₹ 82.63B₹ 66.48B₹ 52.86B₹ 32.79B₹ 53.39B
Net Debt₹ 273.80M₹ 32.54B₹ 8.90B₹ -8.84B₹ -343.90M
Total Liabilities₹ 171.38B₹ 152.21B₹ 130.38B₹ 93.48B₹ 119.25B
Stockholders' Equity₹ 326.53B₹ 298.43B₹ 268.40B₹ 245.76B₹ 219.30B
Cash Flow
Free Cash Flow₹ 19.57B₹ -11.27B₹ -3.34B₹ 23.12B₹ 14.55B
Operating Cash Flow₹ 39.25B₹ 24.35B₹ 23.87B₹ 50.16B₹ 33.29B
Investing Cash Flow₹ -18.76B₹ -45.37B₹ -39.78B₹ -32.12B₹ 5.99B
Financing Cash Flow₹ 1.20B₹ 8.00B₹ 18.14B₹ -29.69B₹ -13.65B
Currency in INR

Aurobindo Pharma Ltd Earnings and Revenue History

Aurobindo Pharma Ltd Debt to Assets

Aurobindo Pharma Ltd Cash Flow

Aurobindo Pharma Ltd Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis